By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CureFAKtor Pharmaceuticals. LLC 

14 Rockdove Ln

Buffalo  New York    U.S.A.
Phone: 716-566-7410 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
CureFAKtor Pharmaceuticals. LLC Demonstrates Novel Focal Adhesion Kinase (FAK) Inhibitor Disrupts FAK-VEGFR3 Interaction and Inhibits Pancreatic Tumor Growth 4/3/2012 11:00:36 AM
CureFAKtor Pharmaceuticals. LLC Demonstrates Novel Focal Adhesion Kinase (FAK) Inhibitor Y15 Decreased Glioblastoma Tumor Growth & Increased Lung & Colon Cancer Cell Death 11/14/2011 1:49:31 PM
CureFAKtor Pharmaceuticals. LLC Demonstrates Novel Focal Adhesion Kinase (FAK) Inhibitor C4 Analogs Inhibited Pancreatic Cancer Tumor Growth as Single Agents 11/14/2011 1:15:52 PM
CureFAKtor Pharmaceuticals. LLC to Present at 10th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/19/2011 11:24:31 AM
CureFAKtor Pharmaceuticals. LLC Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density 6/23/2011 9:15:04 AM
CureFAKtor Pharmaceuticals. LLC Featured at University of Florida Innovation Showcase 2011 4/19/2011 7:23:18 AM
CureFAKtor Pharmaceuticals. LLC Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth 1/21/2011 6:31:43 AM
CureFAKtor Pharmaceuticals. LLC Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer 1/18/2011 10:28:36 AM
//-->